The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19
- PMID: 32598164
- PMCID: PMC7384266
- DOI: 10.7326/M20-3106
The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19
Abstract
Although the number of clinical trials for patients with COVID-19 is increasing, many exclude pregnant women as participants or do not address pregnancy. This commentary discuss why pregnancy women should be included in clinical trials of interventions for COVID-19.
Conflict of interest statement
Comment in
-
Excerpts from the World Medical Literature: Obstetrics.J Obstet Gynaecol Can. 2021 Apr;43(4):429-431. doi: 10.1016/j.jogc.2021.01.009. J Obstet Gynaecol Can. 2021. PMID: 33766390 Free PMC article. No abstract available.
References
-
- World Health Organization. Coronavirus disease 2019 (COVID-19), Situation Report—152. Accessed at www.who.int/docs/default-source/coronaviruse/situation-reports/20200620-... on 10 June 2020.
-
- Lapinsky SE. Management of acute respiratory failure in pregnancy. Semin Respir Crit Care Med. 2017;38:201-207. [PMID: 28561251] doi:10.1055/s-0037-1600909 - PubMed
-
- Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020:100118. [PMID: 32292903] doi:10.1016/j.ajogmf.2020.100118 - PMC - PubMed
-
- Knight M, Bunch K, Vousden N, et al; UK Obstetric Surveillance System SARS-CoV-2 Infection in Pregnancy Collaborative Group. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020;369:m2107. [PMID: 32513659] doi:10.1136/bmj.m2107 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical